AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitalib M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Libramed Pharmaceuticals Private Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitalib M 50/500 Tablet

Combiflex-DM 50/500 tablets contain a dual-action formula to manage elevated blood glucose in individuals with type 2 diabetes. This helps mitigate serious diabetic complications, including vision impairment and kidney disease, and potentially lowers the risk of cardiovascular events. Combiflex-DM 50/500 may be used independently or in conjunction with other diabetes treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering current health status, blood glucose readings, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under physician supervision. Adherence to the prescribed diet and exercise regimen is crucial for successful diabetes management. Lifestyle choices significantly impact diabetes control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and throat irritation. Low blood sugar (hypoglycemia) is a potential adverse effect when used with insulin or sulfonylureas; understanding its recognition and management is essential. This medication isn't suitable for all patients. Prior to use, inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption. Pregnant or lactating individuals should consult their doctor. Potential drug interactions exist; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its potential to decrease blood sugar. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Sitalib M 50/500 Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Sitalib M 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Sitalib M 50/500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitalib M 50/500 Tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.

Common Side effects of Sitalib M 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitalib M 50/500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitalib M 50/500 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Sitalib M 50/500 Tablet works:

Sitalib M 50/500 tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production from the pancreas, enhances insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action optimizes blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitalib M 50/500 Tablet with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitalib M 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitalib M 50/500 tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitalib M 50/500 Tablets cautiously, potentially requiring dosage modification. Consult your physician. Sitalib M 50/500 Tablets are contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver impairment should likely avoid Sitalib M 50/500 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitalib M 50/500 Tablet :

Should you forget a Sitalib M 50/500 Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitalib M 50/500 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Sitalib M 50/500 Tablet

Sitalib M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. It helps control blood sugar when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not for use in individuals under 18.
Prolonged use of Sitalib M 50/500 Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitalib M 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitalib M 50/500 Tablets are contraindicated in patients with allergies to any ingredient, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalib M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication. Keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Sitalib M 50/500) can cause lactic acidosis, a serious, potentially fatal buildup of lactic acid in the blood (also known as MALA—Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Sitalib M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitalib M 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitalib M 50/500 Tablets are contraindicated in patients with known allergies to any component or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalib M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitalib M 50/500) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitalib M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), and balance problems. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Sitalib M 50/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. It helps control blood sugar levels when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitalib M 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitalib M 50/500 Tablets are contraindicated in patients with known allergies to its ingredients or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalib M 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitalib M 50/500) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also called Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged use of Sitalib M 50/500 Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), requiring supplemental vitamin B12, possibly annually, as suggested by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitalib M 50/500 Tablet
167
MRP 194
13% off